VIEWS: 6 PAGES: 59 CATEGORY: Market and Industry Reports POSTED ON: 11/10/2011
Dyspepsia - Pipeline Review, H2 2011
Global Markets Direct’s, 'Dyspepsia - Pipeline Review, H2 2011', provides an overview of the Dyspepsia therapeutic pipeline. This report provides information on the therapeutic development for Dyspepsia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dyspepsia. 'Dyspepsia - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- A snapshot of the global therapeutic scenario for Dyspepsia.
- A review of the Dyspepsia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dyspepsia pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Dyspepsia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisi
Dyspepsia – Pipeline Review, H2 2011 Dyspepsia - Pipeline Review, H2 2011 Reference Code: GMDHC1276IDB Publication Date: August 2011 Dyspepsia – Pipeline Review, H2 2011 GMDHC1276IDB / Pub August 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(1) Dyspepsia – Pipeline Review, H2 2011 Ta b le o f Co n te n ts Table of Contents 2 List of Tables 5 List of Figures 6 Introduction 7 Global Markets Direct Report Coverage 7 Dyspepsia Overview 8 Therapeutics Development 9 An Overview of Pipeline Products for Dyspepsia 9 Dyspepsia Therapeutics under Development by Companies 11 Dyspepsia Therapeutics under Investigation by Universities/Institutes 13 Late Stage Products 14 Comparative Analysis 14 Mid Clinical Stage Products 15 Comparative Analysis 15 Early Clinical Stage Products 16 Comparative Analysis 16 Discovery and Pre-Clinical Stage Products 17 Comparative Analysis 17 Dyspepsia Therapeutics - Products under Development by Companies 18 Dyspepsia Therapeutics - Products under Investigation by Universities/Institutes 19 Companies Involved in Dyspepsia Therapeutics Development 20 GlaxoSmithKline plc 20 Daewoong Pharmaceutical Co., Ltd. 20 Dong-A Pharmaceutical Co., Ltd. 21 Zeria Pharmaceutical Co Ltd 21 ARYx Therapeutics 22 Tranzyme Pharma, Inc. 22 Rottapharm SpA 23 RaQualia Pharma Inc. 23 Dyspepsia - Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Combination Products 25 Assessment by Route of Administration 26 Assessment by Molecule Type 28 Drug Profiles 30 Z-338 - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 GSK962040 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 ATI-7505 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Dyspepsia – Pipeline Review, H2 2011 GMDHC1276IDB / Pub August 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(2) Dyspepsia – Pipeline Review, H2 2011 IMD3 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 TZP-102 - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 OPC-12759E - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 CR 2017 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 CR 2945 - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 DA-6650 - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 RQ-00201894 - Drug Profile 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 Amoxicillin + Clarythromycin + Omeprazole - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 DA-9701 - Drug Profile 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 Amitriptyline - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 Rabeprazole - Drug Profile 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 Rebamipide - Drug Profile 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 Dyspepsia – Pipeline Review, H2 2011 GMDHC1276IDB / Pub August 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(3) Dyspepsia – Pipeline Review, H2 2011 Imipramine - Drug Profile 48 Product Description 48 Mechanism of Action 48 R&D Progress 48 Nigella Sativa Seeds + Omeprazole - Drug Profile 49 Product Description 49 Mechanism of Action 49 R&D Progress 49 Clarithromycin + Amoxicillin + Omeprazole - Drug Profile 50 Product Description 50 Mechanism of Action 50 R&D Progress 50 Dyspepsia Therapeutics – Drug Profile Updates 52 Dyspepsia Therapeutics - Discontinued Products 55 Dyspepsia - Featured News 56 Sep 29, 2010: Zeria And Astellas Pharma Submit NDA Of Z-338 /YM443 For Functional Dyspepsia In Japan 56 Jun 28, 2010: Zeria Announces Positive Phase III Trial Results Of Z-338 In Dyspepsia 56 Appendix 58 Methodology 58 Coverage 58 Secondary Research 58 Primary Research 58 Expert Panel Validation 59 Contact Us 59 Disclaimer 59 Dyspepsia – Pipeline Review, H2 2011 GMDHC1276IDB / Pub August 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(4) Dyspepsia – Pipeline Review, H2 2011 Lis t o f Ta b le s Number of Products Under Development for Dyspepsia, H2 2011 9 Products under Development for Dyspepsia – Comparative Analysis, H2 2011 10 Number of Products under Developme
Pages to are hidden for
"Dyspepsia - Pipeline Review, H2 2011"Please download to view full document